Letter to Shareholders regarding Annual Report FY 2025-26

CSD/SE/2026-27 Date: July 30, 2026 To To Listing Department Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Please note that in terms of the provisions of Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the letter being issued to shareholders whose e-mail address is not registered with the Company / RTA / Depository Participants, providing the web-link, including the exact path, where complete details of the Annual Report is available on the Company’s website. This is for your information and record. Thanking you. For Suven Life Sciences Limited K.Sangeetha Laxmi Company Secretary Encl.: As above Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Email: info@suven.com website: www.suven.com SAMPLE Suven Life Sciences Limited Regd. Office: 8-2-334 I SDE Serene Chambers I 6th Floor I Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500034 I Telangana I India Tel: +91-40-2354 1142/ 1152 CIN: L24110TG1989PLC009713 Email: investorservices@suven.com; website: www.suven.com Date: 30 July, 2026 Folio No. / DP Id Client Id: Dear Shareholder, Subject: Web-link of the Annual Report for the Financial Year ended 31 March 2026 In accordance with Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Annual Report of Suven Life Sciences Limited for Financial Year ended 31 March 2026 has been emailed to the shareholders whose email address has been registered with the Depository Participants / Registrar and Transfer Agent (RTA). In absence of your email id being registered with the Depository Participant / RTA, pursuant to the Regulation 36(1)(b), please find below the path to access the Annual Report from the website of Company: Path: https://www.suven.com/annualreports.aspx By scanning the QR code provided below: Path: www.suven.com Home >> Investors >> Financial Info >> Annual Reports >> Annual Report FY 2025-2026 As per SEBI guidelines, it is mandatory for shareholders to update their PAN, KYC details (including postal address with pin code, email address, mobile number, bank account details), and nomination details. We kindly request you to update your KYC and submit the required documents/information to your respective Depository Participant / RTA at einward.ris@kfintech.com at the earliest convenience. Furthermore, any payments, including dividends, for folios where PAN or KYC details are not updated, will only be made electronically upon the registration of the required information. We would also like to draw attention of our shareholders to Senior Citizens Investor Cell which has been formed by our RTA to assist exclusively the shareholders who are senior citizens (above 60 years of age) in redressing their grievances, complaints and queries. The senior citizens wishing to avail this service can send the communication to senior.citizen@kfintech.com. A dedicated toll-free number 1800 3094 006 is also provided for the convenience of the senior citizens We appreciate your prompt attention to this letter. For any queries or further assistance, please reach out to the RTA at einward.ris@kfintech.com. For Suven Life Sciences Limited Sd/- K.Sangeetha Laxmi Company Secretary & Compliance officer